Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine.

@article{Friedman1997HealthcareDA,
  title={Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine.},
  author={Carola P Friedman and D. Romeo and Sharon Hinton},
  journal={The American journal of medicine},
  year={1997},
  volume={102 2A},
  pages={
          50-6
        }
}
This study was designed to determine whether randomly selected subjects could comprehend prototype consumer-oriented package labeling and inserts for over-the-counter cholestyramine, a nonsystemic lipid-lowering agent. The primary messages communicated in the label were that consumers should see their doctor before taking cholestyramine and should read the full package insert. In addition, the label communicated indication, dosage, and preparation, as well as key warnings about use with other… CONTINUE READING
BETA